Text Size
A A A
Skip Navigation

Home > RePORTER > Project Information

Project InformationProject Information Help

Project Number: 2R01DA017173-06A2 Contact PI / Project Leader: DE BIASI, MARIELLA
Title: STRESS, ANXIETY, AND NICOTINE WITHDRAWAL Awardee Organization: BAYLOR COLLEGE OF MEDICINE
Description
Abstract Text:
Nicotine addiction is a major worldwide medical and social problem that continues to escalate. Affective and somatic symptoms associated with nicotine withdrawal contribute to the difficulty in quitting tobacco use. While current therapies for smoking cessation are helpful, none can claim a very high rate of success. Therefore, there is a great need for a better understanding of the behavioral and biological factors underlying nicotine withdrawal. Stress and anxiety play an important role in the maintenance of nicotine abuse. Anxiety promotes cigarette use and it is also one of the symptoms of withdrawal, making tobacco abstinence more difficult. This application builds on the observation that lack of (4* or ¿5* nicotinic acetylcholine receptors (nAChRs) significantly reduces somatic signs of withdrawal and reduces anxiety-like responses. (4* and ¿5* nAChRs are prominently expressed in the medial habenula/interpeduncular nucleus (MHb/IPN) axis. The habenula is a source of negative reward signals and participates in a wide array of behaviors including anxiety and stress. We postulate that (4* and ¿5* nAChRs in the MHb/IPN axis are in a key position to influence the mesolimbic dopamine system during nicotine withdrawal. Control mice and mice lacking the (4 or the ¿5 nAChR subunit will be chronically treated with nicotine delivered in the drinking water, and withdrawal will be precipitated by injection of the nAChR antagonist mecamylamine. First, we will examine the role of (4* and ¿5* nAChRs on anxiety-related responses during withdrawal using a battery of behavioral paradigms. Second, we will ask which manifestations of nicotine withdrawal are directly influenced by the (4* and ¿5* nAChRs expressed in the MHb/ IPN axis. In those experiments, lentiviral vectors will be used to either re-express (4 or ¿5 in the MHb or the IPN of (4 and ¿5 null mice or to knock down the levels of ¿5 and ¿4 in MHb and IPN of wild type mice.
Public Health Relevance Statement:
Our studies will take advantage of genetically engineered mice and novel genetic techniques, and will combine behavioral analysis, molecular biology, and pharmacology to study the complex interaction between nicotine, stress and anxiety. The goal is to identify possible pharmacological targets that will help develop effective smoking-cessation aids.
NIH Spending Category:
Basic Behavioral and Social Science; Behavioral and Social Science; Depression; Drug Abuse (NIDA only); Genetics; Mental Health; Neurosciences; Smoking and Health; Substance Abuse; Tobacco
Project Terms:
Abstinence; Address; Affective; Affective Symptoms; Anxiety; Area; aversive conditioning; Back; base; Behavior; Behavioral; Behavioral Paradigm; Biological Factors; Boxing; Brain; Brain region; Chronic; Cigarette; Complex; Corticosterone; depression; Dimensions; drinking water; Drosophila acetylcholine receptor alpha-subunit; drug abuse nicotine; drug withdrawal; Estrus; Female; genetic manipulation; Genetic Techniques; Genetically Engineered Mouse; Goals; Habenula; Home environment; Injection of therapeutic agent; interpeduncular nucleus; Intraperitoneal Injections; Investigation; knock-down; Knockout Mice; Lentivirus Vector; Maintenance; male; Measures; Mecamylamine; Medial; Medical; mesolimbic system; Microinjections; Molecular Biology; Monitor; Mus; mutant; Nicotine; Nicotine Dependence; Nicotine Withdrawal; Nicotinic Receptors; novel; Pharmaceutical Preparations; Pharmacology; Phase; Plasma; Play; Positioning Attribute; Proteins; research study; response; Rewards; Role; Sex Characteristics; Signal Transduction; smoking cessation; Social Problems; Source; Stress; Subfamily lentivirinae; Substance Withdrawal Syndrome; success; Symptoms; Tail Suspension; Testing; Time; tobacco abstinence; Tobacco use; Validation; Wild Type Mouse; Withdrawal; Withdrawal Symptom



The RePORTER database is available to all public users at http://exporter.nih.gov/. As the data are available for bulk download, the RePORTER system reserves the right to block IP addresses that fail to adhere to instructions in the system’s robots.txt files or submit requests at a rate that negatively impacts service delivery to other users. RePORTER reserves the right to terminate any automated query to the RePORTER application that negatively affects service delivery to other users.

Page Last Updated on March 18, 2013
This site is best viewed with Internet Explorer (7.0 or higher) or Mozilla Firefox (3.0).

NIH...Turning Discovery Into Health®
RePORTER2